The U.S. Food and Drug Administration is set to give Pfizer-BioNTech authorization for its COVID-19 vaccine to be used on people between the ages of 12 and 15. A government official told CNN that Pfizer applied for emergency use authorization and the 'process should be straightforward.' The FDA is currently reviewing data submitted to support the extended use. A clinical trial involving more than 2,000 12-to-15-year-olds revealed that the vaccine was well tolerated. It had an efficacy rate of 100% within the age group. RELATED: Pfizer, BioNTech COVID-19 vaccine 100% effective in children 12 - 15 Although children are less […]
The post Pfizer set to authorize COVID-19 vaccine for children, teens age 12 to 15 appeared first on BNC.
